Study of GS-4321 in Healthy Participants and Participants With Chronic Hepatitis Delta Virus

NCT07096193 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

107

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Hepatitis Delta

Interventions

DRUG: GS-4321
DRUG: GS-4321 Placebo
DRUG: GS-4321

Sponsor

Gilead Sciences